BVCF — 2014 Investments

2 investments dated 2014 · listed companies and verified rows first · show all

Jaguar Healthjaguar.healthNASDAQ: JAGXSeries A · Feb 2014 · $7M

Jaguar Health is a pharmaceutical company developing crofelemer, including a novel powder for oral solution formulation, for gastrointestinal conditions and rare intestinal failure indications such as microvillus inclusion disease (MVID) and short bowel syndrome with intestinal failure (SBS-IF) in adults and children.

BiotechDigital HealthHealthtechSan Francisco, US

Lisa Conte(Executive Officer, Director)Carol Lizak(Executive Officer)Pravin Chaturvedi(Executive Officer)Steven King(Executive Officer)inJonathan Wolin(Executive Officer)inSerge Martinod(Executive Officer)

Co-investorsDigitalDx Ventures

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

CARsgen Therapeutics

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.